CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 54 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $18,703 | +66696.4% | 43,105 | -0.3% | 0.02% | -34.2% |
| Q4 2022 | $28 | -99.9% | 43,215 | -10.6% | 0.04% | -34.5% |
| Q3 2022 | $42,000 | +55.6% | 48,315 | 0.0% | 0.06% | +70.6% |
| Q2 2022 | $27,000 | -50.9% | 48,315 | -3.2% | 0.03% | -41.4% |
| Q1 2022 | $55,000 | -36.8% | 49,915 | -1.5% | 0.06% | -37.6% |
| Q4 2021 | $87,000 | – | 50,665 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
| Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
| MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
| Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
| Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
| COLONY GROUP LLC | 102,884 | $44 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
| STATE STREET CORP | 115,414 | $50,078 | 0.00% |